✦ LIBER ✦

285 Analysis of two differently glycosylated forms of human recombinant rt-PA

✍ Scribed by Hoffmann, H.; Schlüter, M.; Walter, J.; Berthold, W.; Werner, R.G.

Book ID: 122850561
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 43 KB
Volume: 2
Category: Article
ISSN: 0268-9499
DOI: 10.1016/0268-9499(88)90632-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EXPRESSION ANALYSIS AND PURIFICATION OF

EXPRESSION ANALYSIS AND PURIFICATION OF HUMAN RECOMBINANT TISSUE TYPE PLASMINOGEN ACTIVATOR (rt-PA) FROM TRANSGENIC TOBACCO PLANTS

✍ Nabiabad, Haidar Saify; Yaghoobi, Mohammad Mehdi; Javaran, Mokhtar Jalali; Hosse 📂 Article 📅 2011 🏛 Taylor and Francis Group 🌐 English ⚖ 306 KB

Structural and functional differences am

Structural and functional differences among purified recombinant mammalian aromatases: glycosylation, N-terminal sequence and kinetic analysis of human, bovine and the porcine placental and gonadal isozymes

✍ C Jo Corbin; S.M Mapes; Young M Lee; Alan J Conley 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Quality of life (QOL) differentiation an

Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)

✍ Salim Daya; Matts Wikland; Kaylen M. Silverberg; Selina Blatz; Gerard Duru; Arie 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

PWH5 QUALITY OF LIFE (QOL) DIFFERENTIATI

PWH5 QUALITY OF LIFE (QOL) DIFFERENTIATION ANALYSIS IN PATIENTS UNDERGOING CONTROLLED OVARIAN STIMULATION (COS) WITH TWO DIFFERENT PREPARATIONS OF RECOMBINANT HUMAN FOLLICLESTIMULATING HORMONE (R-HFSH)

✍ A Beresniak; P Brasseur; S Daya; K Silverberg; M Wikland; G Duru; G Decostered; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PWH5 QUALITY OF LIFE (QOL) DIFFERENTIATI

✍ A Beresniak; P Brasseur; S Daya; K Silverberg; M Wikland; G Duru; G Decostered; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

A RANDOMIZED PHASE II TRIAL COMPARING TW

A RANDOMIZED PHASE II TRIAL COMPARING TWO DIFFERENT SEQUENCE COMBINATIONS OF AUTOLOGOUS VACCINE AND HUMAN RECOMBINANT INTERFERON γ AND HUMAN RECOMBINANT INTERFERON α2B THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: CLINICAL OUTCOME AND ANALYSIS OF IMMUNOLOGICAL PARAMETERS

✍ SCHWAAB, THOMAS; HEANEY, JOHN A.; SCHNED, ALAN R.; HARRIS, ROBERT D.; COLE, BERN 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB